AdaptHealth (AHCO) Gains from Sales and Divestitures (2020 - 2022)

AdaptHealth's Gains from Sales and Divestitures history runs 3 years deep, the most recent figure standing at $461000.0 for Q3 2022.

• In Q3 2022, Gains from Sales and Divestitures rose 37.61% year-over-year to $461000.0; the TTM figure through Sep 2022 stood at $461000.0 (up 37.61% YoY), while the FY2021 annual figure was $556000.0, up 2.77% from the prior year.
• Gains from Sales and Divestitures was $461000.0 for Q3 2022 at AdaptHealth, up from $350000.0 in the prior quarter.
• In the past five years, Gains from Sales and Divestitures ranged from a high of $556000.0 in Q4 2021 to a low of $15417.0 in Q1 2020.
• Historically, Gains from Sales and Divestitures has averaged $257037.9 across 3 years, with a median of $230000.0 in 2022.
• Biggest YoY gain for Gains from Sales and Divestitures was 680.0% in 2021; the steepest drop was 2.77% in 2021.
• A 3-year view of Gains from Sales and Divestitures shows it stood at $541000.0 in 2020, then increased by 2.77% to $556000.0 in 2021, then dropped by 17.09% to $461000.0 in 2022.
• The last three Gains from Sales and Divestitures figures came in at $461000.0 (Q3 2022), $350000.0 (Q2 2022), and $230000.0 (Q1 2022), per Business Quant data.